Does ADALIMUMAB Cause Breast cancer? 894 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 894 reports of Breast cancer have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.2% of all adverse event reports for ADALIMUMAB.
894
Reports of Breast cancer with ADALIMUMAB
0.2%
of all ADALIMUMAB reports
31
Deaths
123
Hospitalizations
How Dangerous Is Breast cancer From ADALIMUMAB?
Of the 894 reports, 31 (3.5%) resulted in death, 123 (13.8%) required hospitalization, and 28 (3.1%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 894 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
INTERFERON BETA-1A (610)
Which ADALIMUMAB Alternatives Have Lower Breast cancer Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB